At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 24 enrolled
Drug / intervention
Trazodone HCl +1 moredrug
Likely dose
Trazodone HCl 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Crossover Comparative Bioavailability Study of Trazodone Contramid(r) OAD 300 mg Extended-release Caplets and Desyrel(r) 100 mg Immediate-release Tablets in Healthy Adult Volunteers Under Fasting Conditions
In Brief
A Phase 1 clinical trial evaluating Trazodone HCl for Healthy. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The objective of the study is to compare the pharmacokinetic profiles of extended-release and immediate-release trazodone formulations
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
CollaboratorsAlgorithme Pharma Inc
Timeline
Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
Primary CompletionFeb 2009
First PostedFeb 2009
Study CompletionMar 2009
TodayJul 2026
First PostedFeb 9, 2009
Enrollment StartFeb 1, 2009
Primary CompletionFeb 1, 2009
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 17.4 years ago
Interventions
Trazodone HCldrug
100 mg immediate-release tablet, dosing q8h
Trazodone HCldrug
300 mg extended-release caplet, single dose